α-N-Acetylglucosaminidase from Bifidobacterium bifidum specifically hydrolyzes α-linked N-acetylglucosamine at nonreducing terminus of O-glycan on gastric mucin

Applied Microbiology and Biotechnology

Volumn 99, Issue 9, 2015, Pages 3941-3948

  Shimada, Yoshimi ^a   Watanabe, Yuka ^b   Wakinaka, Takura ^b   Funeno, Yoshihisa ^a   Kubota, Masayuki ^a   Chaiwangsri, Thida ^c   Kurihara, Shin ^d   Yamamoto, Kenji ^d   Katayama, Takane ^d   Ashida, Hisashi ^a  

^a KINKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF PHAYAO   (Thailand)

^d ISHIKAWA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Bifidobacterium bifidum; CBM32; GH89; Mucin; Probiotics; N Acetylglucosaminidase

Indexed keywords

POLYSACCHARIDES;

BIFIDOBACTERIUM BIFIDUM; CBM32; GH89; MUCIN; N-ACETYLGLUCOSAMINIDASE; PROBIOTICS;

ENZYME ACTIVITY;

ALPHA N ACETYLGLUCOSAMINIDASE; GLYCAN; N ACETYLGLUCOSAMINE; STOMACH MUCIN; ACETYLGLUCOSAMINIDASE; ALPHA-N-ACETYL-D-GLUCOSAMINIDASE;

BACTERIUM; CARBOHYDRATE; ENZYME ACTIVITY; PROBIOTICS;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM BIFIDUM; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; ESCHERICHIA COLI; HYDROLYSIS; NONHUMAN; PROTEIN DOMAIN; BIFIDOBACTERIUM; BINDING SITE; ENZYMOLOGY; METABOLISM;

BIFIDOBACTERIUM BIFIDUM; SUS;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; BIFIDOBACTERIUM; BINDING SITES; GASTRIC MUCINS;

EID: 84938215915     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-6201-x     Document Type: Article

References (29)

1. Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M (2011) Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem 286:34583–34592
2. Ashida H, Anderson K, Nakayama J, Maskos K, Chou CW, Cole RB, Li SC, Li YT (2001) A novel endo-β-galactosidase from Clostridium perfringens that liberates the disaccharide GlcNAcα1 → 4Gal from glycans specifically expressed in the gastric gland mucous cell-type mucin. J Biol Chem 276:28226–28232
3. Ashida H, Maskos K, Li SC, Li YT (2002) Characterization of a novel endo-β-galactosidase specific for releasing the disaccharide GlcNAcα1 → 4Gal from glycoconjugates. Biochemistry 41:2388–2395
4. Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, Kumagai H, Katayama T, Yamamoto K (2009) Two distinct α-l-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19:1010–1017
5. Ficko-Blean E, Boraston AB (2012) Structural analysis of a bacterial exo-α-d-N-acetylglucosaminidase in complex with an unusual disaccharide found in class III mucin. Glycobiology 22:590–595
6. Ficko-Blean E, Stubbs KA, Nemirovsky O, Vocadlo DJ, Boraston AB (2008) Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB. Proc Natl Acad Sci U S A 105:6560–6565
7. Ficko-Blean E, Stuart CP, Suits MD, Cid M, Tessier M, Woods RJ, Boraston AB (2012) Carbohydrate recognition by an architecturally complex α-N-acetylglucosaminidase from Clostridium perfringens. PLoS One 7:e33524
8. Fujita K, Oura F, Nagamine N, Katayama T, Hiratake J, Sakata K, Kumagai H, Yamamoto K (2005) Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-α-N-acetylgalactosaminidase from Bifidobacterium longum. J Biol Chem 280:37415–37422
9. Fujita M, Tsuchida A, Hirata A, Kobayashi N, Goto K, Osumi K, Hirose Y, Nakayama J, Yamanoi T, Ashida H, Mizuno M (2011) Glycoside hydrolase family 89 α-N-acetylglucosaminidase from Clostridium perfringens specifically acts on GlcNAcα1,4Galβ1R at the non-reducing terminus of O-glycans in gastric mucin. J Biol Chem 286:6479–6489
10. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543–547
11. Grondin JM, Chitayat S, Ficko-Blean E, Houliston S, Arrowsmith CH, Boraston AB, Smith SP (2014) An unusual mode of galactose recognition by a family 32 carbohydrate-binding module. J Mol Biol 426:869–880
12. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, Sakata K, Yamanoi T, Kumagai H, Yamamoto K (2004) Molecular cloning and characterization of Bifidobacterium bifidum 1,2-α-l-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 186:4885–4893
13. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J (2004) Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003–1006
14. Kitaoka M, Tian J, Nishimoto M (2005) Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 71:3158–3162
15. Kiyohara M, Tachizawa A, Nishimoto M, Kitaoka M, Ashida H, Yamamoto K (2009) Prebiotic effect of lacto-N-biose I on bifidobacterial growth. Biosci Biotechnol Biochem 73:1175–1179
16. Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto K (2011) An exo-α-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21:437–447
17. Kiyohara M, Nakatomi T, Kurihara S, Fushinobu S, Suzuki H, Tanaka T, Shoda S, Kitaoka M, Katayama T, Yamamoto K, Ashida H (2012) α-N-Acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J Biol Chem 287:693–700
18. Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, Ashida H, Yamamoto K (2010) Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20:1402–1409
19. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C (2005) Review article: bifidobacteria as probiotic agents—physiological effects and clinical benefits. Aliment Pharmacol Ther 22:495–512
20. Sakurama H, Fushinobu S, Hidaka M, Yoshida E, Honda Y, Ashida H, Kitaoka M, Kumagai H, Yamamoto K, Katayama T (2012) 1,3-1,4-α-l-Fucosynthase that specifically introduces Lewis a/x antigens into type-1/2 chains. J Biol Chem 287:16709–16719
21. Sakurama H, Kiyohara M, Wada J, Honda Y, Yamaguchi M, Fukiya S, Yokota A, Ashida H, Kumagai H, Kitaoka M, Yamamoto K, Katayama T (2013) Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression. J Biol Chem 288:25194–25206
22. Suzuki R, Wada J, Katayama T, Fushinobu S, Wakagi T, Shoun H, Sugimoto H, Tanaka A, Kumagai H, Ashida H, Kitaoka M, Yamamoto K (2008) Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I. J Biol Chem 283:13165–13173
23. Trebichavsky I, Rada V, Splichalova A, Splichal I (2009) Cross-talk of human gut with bifidobacteria. Nutr Rev 67:77–82
24. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sanchez B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly D, van Sinderen D, Ventura M (2010) Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 107:19514–19519
25. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr C, Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A, De Bellis G, O’Toole PW, van Sinderen D, Marchesi JR, Ventura M (2012) Diversity of bifidobacteria within the infant gut microbiota. PLoS One 7:e36957
26. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, Kumagai H, Katayama T, Yamamoto K (2008) Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 74:3996–4004
27. Wakinaka T, Kiyohara M, Kurihara S, Hirata A, Chaiwangsri T, Ohnuma T, Fukamizo T, Katayama T, Ashida H, Yamamoto K (2013) Bifidobacterial α-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen. Glycobiology 23:232–240
28. Weber B, Hopwood JJ, Yogalingam G (2001) Expression and characterization of human recombinant and α-N-acetylglucosaminidase. Protein Expr Purif 21:251–259
29. Yoshida E, Sakurama H, Kiyohara M, Nakajima M, Kitaoka M, Ashida H, Hirose J, Katayama T, Yamamoto K, Kumagai H (2012) Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22:361–368